Literature DB >> 17628779

[Renal cell carcinoma associated proteins. Isolation, cloning and immunogenicity evaluation].

A Haferkamp1, M Hohenfellner, R Hautmann, M Zöller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17628779     DOI： 10.1007/s00120-007-1418-2

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  36 in total

Review 1.  Processing of bacterial antigens for peptide presentation on MHC class I molecules.

Authors:  M J Wick; H G Ljunggren
Journal:  Immunol Rev       Date:  1999-12       Impact factor: 12.988

2.  The Salmonella SpiC protein targets the mammalian Hook3 protein function to alter cellular trafficking.

Authors:  Yoram Shotland; Helmut Krämer; Eduardo A Groisman
Journal:  Mol Microbiol       Date:  2003-09       Impact factor: 3.501

3.  Tumor vaccination by Salmonella typhimurium after transformation with a eukaryotic expression vector in mice: impact of a Salmonella typhimurium gene interfering with MHC class I presentation.

Authors:  Susanne Hummel; Ron N Apte; Udi Qimron; Mario Vitacolonna; Angel Porgador; Margot Zöller
Journal:  J Immunother       Date:  2005 Sep-Oct       Impact factor: 4.456

4.  Prophylactic tumor vaccination: comparison of effector mechanisms initiated by protein versus DNA vaccination.

Authors:  M Zöller; O Christ
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

5.  Analysis of the CD40/CD40L role in the sustenance of alloreactive antibody production.

Authors:  A S Shoker; Z R Lun; R Choudry; A Saxena
Journal:  Transpl Immunol       Date:  2001-02       Impact factor: 1.708

6.  Dendritic cell-based cancer immunotherapy targeting MUC-1.

Authors:  J Wierecky; M Mueller; P Brossart
Journal:  Cancer Immunol Immunother       Date:  2005-10-27       Impact factor: 6.968

Review 7.  Vaccination with messenger RNA.

Authors:  Steve Pascolo
Journal:  Methods Mol Med       Date:  2006

8.  Therapeutic dendritic cell vaccination of patients with renal cell carcinoma.

Authors:  Annika Berntsen; Poul F Geertsen; Inge Marie Svane
Journal:  Eur Urol       Date:  2006-04-18       Impact factor: 20.096

9.  Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.

Authors:  M Volm; M Kästel; J Mattern; T Efferth
Journal:  Cancer       Date:  1993-06-15       Impact factor: 6.860

Review 10.  Cancer immunotherapy with mRNA-transfected dendritic cells.

Authors:  Eli Gilboa; Johannes Vieweg
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.